BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Bartolomeis A, Tomasetti C, Iasevoli F. Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism. CNS Drugs 2015;29:773-99. [PMID: 26346901 DOI: 10.1007/s40263-015-0278-3] [Cited by in Crossref: 81] [Cited by in F6Publishing: 81] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 da Silva Cunha TT, Silva RR, Rodrigues DA, de Sena Murteira Pinheiro P, Kronenberger T, Sant'Anna CMR, Noël F, Fraga CAM. Design, Synthesis and Pharmacological Evaluation of Novel Conformationally Restricted N-arylpiperazine Derivatives Characterized as D2/D3 Receptor Ligands, Candidates for the Treatment of Neurodegenerative Diseases. Biomolecules 2022;12:1112. [PMID: 36009006 DOI: 10.3390/biom12081112] [Reference Citation Analysis]
2 Taniya MA, Chung H, Al Mamun A, Alam S, Aziz MA, Emon NU, Islam MM, Hong SS, Podder BR, Ara Mimi A, Aktar Suchi S, Xiao J. Role of Gut Microbiome in Autism Spectrum Disorder and Its Therapeutic Regulation. Front Cell Infect Microbiol 2022;12:915701. [DOI: 10.3389/fcimb.2022.915701] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Jannini TB, Sansone A, Rossi R, Di Lorenzo G, Toscano M, Siracusano A, Jannini EA. Pharmacological strategies for sexual recovery in men undergoing antipsychotic treatment. Expert Opin Pharmacother 2022. [PMID: 35470768 DOI: 10.1080/14656566.2022.2071124] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 de Bartolomeis A, Barone A, Begni V, Riva MA. Present and future antipsychotic drugs: a systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective. Pharmacol Res 2022;:106078. [PMID: 35026403 DOI: 10.1016/j.phrs.2022.106078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Parmar S, Tadavarty R, Sastry BR. G-protein coupled receptors and synaptic plasticity in sleep deprivation. World J Psychiatr 2021; 11(11): 954-980 [PMID: 34888167 DOI: 10.5498/wjp.v11.i11.954] [Reference Citation Analysis]
6 Hirai S, Miwa H, Tanaka T, Toriumi K, Kunii Y, Shimbo H, Sakamoto T, Hino M, Izumi R, Nagaoka A, Yabe H, Nakamachi T, Shioda S, Dan T, Miyata T, Nishito Y, Suzuki K, Miyashita M, Tomoda T, Hikida T, Horiuchi J, Itokawa M, Arai M, Okado H. High-sucrose diets contribute to brain angiopathy with impaired glucose uptake and psychosis-related higher brain dysfunctions in mice. Sci Adv 2021;7:eabl6077. [PMID: 34757783 DOI: 10.1126/sciadv.abl6077] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Gupta B, Chee KS, Neo LQ, Tang C, Hariram J, Tan GC, Verma S, Basu S, Appan DP, Ting CC, Abdin E, Lee J. Effect of aripiprazole as an adjunct to atypical antipsychotics on weight and metabolic profile: a 12-week open-label trial. Ther Adv Psychopharmacol 2021;11:20451253211046765. [PMID: 34646440 DOI: 10.1177/20451253211046765] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Ishigooka J, Nakagome K, Ohmori T, Iwata N, Inada K, Iga JI, Kishi T, Fujita K, Kikuchi Y, Shichijo T, Tabuse H, Koretsune S, Terada H, Terada H, Kishimoto T, Tsutsumi Y, Kanda Y, Ohi K, Sekiyama K. Discontinuation and remission rates and social functioning in patients with schizophrenia receiving second-generation antipsychotics: 52-week evaluation of JUMPs, a randomized, open-label study. Psychiatry Clin Neurosci 2021. [PMID: 34626144 DOI: 10.1111/pcn.13304] [Reference Citation Analysis]
9 Kaur U, Ojha B, Pathak BK, Singh A, Gambhir IS, Chakrabarti SS. Aripiprazole-induced Parkinsonism with pregabalin as a confounder. Acta Neurol Belg 2021;121:1351-6. [PMID: 32444941 DOI: 10.1007/s13760-020-01370-x] [Reference Citation Analysis]
10 Iwashita M, Yoshizawa M. Social-like responses are inducible in asocial Mexican cavefish despite the exhibition of strong repetitive behavior. Elife 2021;10:e72463. [PMID: 34542411 DOI: 10.7554/eLife.72463] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Mason K, Barnett J, Pappa S. Effectiveness of 2-year treatment with aripiprazole long-acting injectable and comparison with paliperidone palmitate. Ther Adv Psychopharmacol 2021;11:20451253211029490. [PMID: 34349980 DOI: 10.1177/20451253211029490] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Kneller LA, Zubiaur P, Koller D, Abad-Santos F, Hempel G. Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach. Clin Pharmacokinet 2021. [PMID: 34125422 DOI: 10.1007/s40262-021-01041-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Xiang J, Xu N, Wang X, Li S, Yu Q, Liang M, Nan F, Shu S, Yan R, Zhu Y, Liao L. Bioequivalence of 2 Aripiprazole Orally Disintegrating Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions. Clin Pharmacol Drug Dev 2021;10:840-9. [PMID: 34105265 DOI: 10.1002/cpdd.954] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Besag FMC, Vasey MJ, Salim I. Is Adjunct Aripiprazole Effective in Treating Hyperprolactinemia Induced by Psychotropic Medication? A Narrative Review. CNS Drugs 2021;35:507-26. [PMID: 33880739 DOI: 10.1007/s40263-021-00812-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Wong MMC, Chung AKK, Yeung TMH, Wong DTW, Lee CK, Lai E, Chan GFY, Mak GKL, Wong JOY, Ng RMK, Tam KL, Mak KY. Consensus statements on the clinical usage and characteristics of aripiprazole for Hong Kong. Intern Med J 2020;50 Suppl 3:6-14. [PMID: 32985093 DOI: 10.1111/imj.14896] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Jalageri MD, Nagaraja A, Puttaiahgowda YM. Piperazine based antimicrobial polymers: a review. RSC Adv 2021;11:15213-30. [DOI: 10.1039/d1ra00341k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
17 Needham EJ, Humphrey SJ, Cooke KC, Fazakerley DJ, Duan X, Parker BL, James DE. Phosphoproteomics of Acute Cell Stressors Targeting Exercise Signaling Networks Reveal Drug Interactions Regulating Protein Secretion. Cell Rep 2019;29:1524-1538.e6. [PMID: 31693893 DOI: 10.1016/j.celrep.2019.10.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
18 Kim DD, Barr AM, White RF, Honer WG, Procyshyn RM. Clozapine-induced obsessive–compulsive symptoms: mechanisms and treatment. J Psychiatry Neurosci 2019;44:71-2. [PMID: 30565908 DOI: 10.1503/jpn.180087] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
19 Mallet J, Gorwood P, Le Strat Y, Dubertret C. Major Depressive Disorder (MDD) and Schizophrenia- Addressing Unmet Needs With Partial Agonists at the D2 Receptor: A Review. Int J Neuropsychopharmacol 2019;22:651-64. [PMID: 31406978 DOI: 10.1093/ijnp/pyz043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 de Bartolomeis A, Manchia M, Marmo F, Vellucci L, Iasevoli F, Barone A. Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia. Front Psychiatry 2020;11:369. [PMID: 32477178 DOI: 10.3389/fpsyt.2020.00369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
21 Koller D, Saiz-Rodríguez M, Zubiaur P, Ochoa D, Almenara S, Román M, Romero-Palacián D, de Miguel-Cáceres A, Martín S, Navares-Gómez M, Mejía G, Wojnicz A, Abad-Santos F. The effects of aripiprazole and olanzapine on pupillary light reflex and its relationship with pharmacogenetics in a randomized multiple-dose trial. Br J Clin Pharmacol 2020;86:2051-62. [PMID: 32250470 DOI: 10.1111/bcp.14300] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
22 Miuli A, Pettorruso M, Romanelli E, Stigliano G, Di Giuda D, De-Giorgio F, Martinotti G, di Giannantonio M. Does DRD2 Taq1A Mediate Aripiprazole-Induced Gambling Disorder? A Pharmacogenetic Hypothesis. Front Psychiatry 2020;11:275. [PMID: 32351415 DOI: 10.3389/fpsyt.2020.00275] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Nesbit MO, Phillips AG. Tetrahydroprotoberberines: A Novel Source of Pharmacotherapies for Substance Use Disorders? Trends Pharmacol Sci 2020;41:147-61. [PMID: 31987662 DOI: 10.1016/j.tips.2019.12.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
24 Ratajczak P, Kus K, Murawiecka P, Słodzińska I, Zaprutko T, Kopciuch D, Paczkowska A, Nowakowska E. Memory deterioration based on the tobacco smoke exposure and methylazoxymethanol acetate administration vs. aripiprazole, olanzapine and enrichment environment conditions. Pharmacol Biochem Behav 2020;189:172855. [PMID: 31954117 DOI: 10.1016/j.pbb.2020.172855] [Reference Citation Analysis]
25 García Álvarez JC, González Sánchez L, García Resa E, Bonete Llácer JM, Román Rodríguez A, Pecino Esquerdo B, Pérez Martínez E. Clinical evolution of patients treated with aripiprazole long-acting injectable: a preliminary, prospective, observational study. Int J Psychiatry Clin Pract 2020;24:10-7. [PMID: 31933402 DOI: 10.1080/13651501.2019.1711130] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 de Bartolomeis A, Avagliano C, Vellucci L, D’ambrosio L, Manchia M, D’urso G, Buonaguro EF, Iasevoli F. Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia. Neuroscience & Biobehavioral Reviews 2019;107:795-827. [DOI: 10.1016/j.neubiorev.2019.08.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
27 Castanheira L, Fernandes E, Levy P, Coentre R. Aripiprazole-induced Hepatitis: A Case Report. Clin Psychopharmacol Neurosci 2019;17:551-5. [PMID: 31671495 DOI: 10.9758/cpn.2019.17.4.551] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
28 Kułaga D, Jaśkowska J, Satała G. Design, synthesis and biological evaluation of novel serotonin and dopamine receptor ligands being 6-bromohexyl saccharine derivatives. Bioorg Med Chem Lett 2019;29:126667. [PMID: 31547945 DOI: 10.1016/j.bmcl.2019.126667] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
29 Tveito M, Molden E, Høiseth G, Correll CU, Smith RL. Impact of age and CYP2D6 genetics on exposure of aripiprazole and dehydroaripiprazole in patients using long-acting injectable versus oral formulation: relevance of poor and intermediate metabolizer status. Eur J Clin Pharmacol 2020;76:41-9. [PMID: 31637453 DOI: 10.1007/s00228-019-02768-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
30 Fluyau D, Mitra P, Lorthe K. Antipsychotics for Amphetamine Psychosis. A Systematic Review. Front Psychiatry 2019;10:740. [PMID: 31681046 DOI: 10.3389/fpsyt.2019.00740] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
31 Berg KA, Clarke WP. Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity. Int J Neuropsychopharmacol 2018;21:962-77. [PMID: 30085126 DOI: 10.1093/ijnp/pyy071] [Cited by in Crossref: 38] [Cited by in F6Publishing: 48] [Article Influence: 12.7] [Reference Citation Analysis]
32 Pereira JEM, Eckert J, Rudic S, Yu D, Mole R, Tsapatsaris N, Bordallo HN. Hydrogen bond dynamics and conformational flexibility in antipsychotics. Phys Chem Chem Phys 2019;21:15463-70. [PMID: 31257373 DOI: 10.1039/c9cp02456e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Kiss A, Osacka J. Spatial relationship between the c-Fos distribution and enkephalinergic, substance P, and tyrosine hydroxylase innervation fields after acute treatment with neuroleptics olanzapine, amisulpride, quetiapine, and aripiprazole in the rat septum. Endocr Regul 2019;53:165-77. [PMID: 31517634 DOI: 10.2478/enr-2019-0017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Bartram LA, Lozano J, Coury DL. Aripiprazole for treating irritability associated with autism spectrum disorders. Expert Opinion on Pharmacotherapy 2019;20:1421-7. [DOI: 10.1080/14656566.2019.1626825] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
35 Cuomo A, Beccarini Crescenzi B, Goracci A, Bolognesi S, Giordano N, Rossi R, Facchi E, Neal SM, Fagiolini A. Drug safety evaluation of aripiprazole in bipolar disorder. Expert Opinion on Drug Safety 2019;18:455-63. [DOI: 10.1080/14740338.2019.1617847] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
36 Lapointe T, Hudson R, Daniels S, Melanson B, Zhou Y, Leri F. Effects of combined escitalopram and aripiprazole in rats: role of the 5-HT1a receptor. Psychopharmacology 2019;236:2273-81. [DOI: 10.1007/s00213-019-05225-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
37 Iannuzzi GL, Patel AA, Stewart JT. Aripiprazole and Delusional Disorder. J Psychiatr Pract 2019;25:132-4. [PMID: 30849061 DOI: 10.1097/PRA.0000000000000368] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
38 Luo T, Liu QS, Yang YJ, Wei B. Aripiprazole for the treatment of duloxetine-induced hyperprolactinemia: A case report. J Affect Disord 2019;250:330-2. [PMID: 30875676 DOI: 10.1016/j.jad.2019.03.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
39 Mazahery H, Conlon CA, Beck KL, Mugridge O, Kruger MC, Stonehouse W, Camargo CA, Meyer BJ, Jones B, von Hurst PR. A randomised controlled trial of vitamin D and omega-3 long chain polyunsaturated fatty acids in the treatment of irritability and hyperactivity among children with autism spectrum disorder. The Journal of Steroid Biochemistry and Molecular Biology 2019;187:9-16. [DOI: 10.1016/j.jsbmb.2018.10.017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
40 Moccia L, Tofani A, Mazza M, Covino M, Martinotti G, Schifano F, Janiri L, Di Nicola M. Dorsolateral Prefrontal Cortex Impairment in Methoxetamine-Induced Psychosis: An 18F-FDG PET/CT Case Study. J Psychoactive Drugs 2019;51:254-9. [PMID: 30741111 DOI: 10.1080/02791072.2019.1578444] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
41 Zheng P, Hu M, Xie Y, Yu Y, Jaaro-Peled H, Huang XF. Aripiprazole and haloperidol protect neurite lesions via reducing excessive D2R-DISC1 complex formation. Prog Neuropsychopharmacol Biol Psychiatry 2019;92:59-69. [PMID: 30597182 DOI: 10.1016/j.pnpbp.2018.12.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
42 Simon N, Azorin JM. [Aripiprazole as dopamine partial agonist model: Basic concepts and clinical impact]. Encephale 2018;44:558-64. [PMID: 30466778 DOI: 10.1016/j.encep.2018.10.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Koller D, Belmonte C, Lubomirov R, Saiz-rodríguez M, Zubiaur P, Román M, Ochoa D, Carcas A, Wojnicz A, Abad-santos F. Effects of aripiprazole on pupillometric parameters related to pharmacokinetics and pharmacogenetics after single oral administration to healthy subjects. J Psychopharmacol 2018;32:1212-22. [DOI: 10.1177/0269881118798605] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
44 Osuna-Luque J, Rodríguez-Ramos Á, Gámez-Del-Estal MDM, Ruiz-Rubio M. Behavioral Mechanisms That Depend on Dopamine and Serotonin in Caenorhabditis elegans Interact With the Antipsychotics Risperidone and Aripiprazole. J Exp Neurosci 2018;12:1179069518798628. [PMID: 30245571 DOI: 10.1177/1179069518798628] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
45 Hebbrecht K, Morrens M, Neels H, Roosens L, Sabbe BGC. Pharmacokinetic evaluation of the aripiprazole (once-monthly) injection for the treatment of bipolar disorder. Expert Opinion on Drug Metabolism & Toxicology 2018;14:999-1005. [DOI: 10.1080/17425255.2018.1515911] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
46 Jóźwiak-Bębenista M, Jasińska-Stroschein M, Kowalczyk E. Involvement of vascular endothelial growth factor (VEGF) and mitogen-activated protein kinases (MAPK) in the mechanism of neuroleptic drugs. Pharmacol Rep 2018;70:1032-9. [PMID: 30144664 DOI: 10.1016/j.pharep.2018.05.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
47 Tuplin EW, Holahan MR. Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity. Curr Neuropharmacol 2017;15:1192-207. [PMID: 28412910 DOI: 10.2174/1570159X15666170413115754] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
48 Veselinović T, Vernaleken I, Cumming P, Henning U, Winkler L, Kaleta P, Paulzen M, Luckhaus C, Gründer G. Antidopaminergic medication in healthy subjects provokes subjective and objective mental impairments tightly correlated with perturbation of biogenic monoamine metabolism and prolactin secretion. Neuropsychiatr Dis Treat 2018;14:1125-38. [PMID: 29731635 DOI: 10.2147/NDT.S148557] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
49 Gallo FT, Katche C, Morici JF, Medina JH, Weisstaub NV. Immediate Early Genes, Memory and Psychiatric Disorders: Focus on c-Fos, Egr1 and Arc. Front Behav Neurosci 2018;12:79. [PMID: 29755331 DOI: 10.3389/fnbeh.2018.00079] [Cited by in Crossref: 97] [Cited by in F6Publishing: 127] [Article Influence: 24.3] [Reference Citation Analysis]
50 Torbic H, Duggal A. Antipsychotics, Delirium, and Acute Respiratory Distress Syndrome: What Is the Link? Pharmacotherapy 2018;38:462-9. [PMID: 29444340 DOI: 10.1002/phar.2093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
51 Rabinowitz SS, Ahuja N, Gottfried J. Aripiprazole reversed gastroparesis in a child with 1q21.1-q21.2 microdeletion. BMJ Case Rep 2018;2018:bcr-2017-223231. [PMID: 29545430 DOI: 10.1136/bcr-2017-223231] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Wojnicz A, Belmonte C, Koller D, Ruiz-nuño A, Román M, Ochoa D, Abad-santos F. Effective phospholipids removing microelution-solid phase extraction LC-MS/MS method for simultaneous plasma quantification of aripiprazole and dehydro-aripiprazole: Application to human pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis 2018;151:116-25. [DOI: 10.1016/j.jpba.2017.12.049] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
53 Barnes SA, Young JW, Markou A, Adham N, Gyertyán I, Kiss B. The Effects of Cariprazine and Aripiprazole on PCP-Induced Deficits on Attention Assessed in the 5-Choice Serial Reaction Time Task. Psychopharmacology (Berl) 2018;235:1403-14. [PMID: 29473089 DOI: 10.1007/s00213-018-4857-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
54 Amato D, Vernon AC, Papaleo F. Dopamine, the antipsychotic molecule: A perspective on mechanisms underlying antipsychotic response variability. Neuroscience & Biobehavioral Reviews 2018;85:146-59. [DOI: 10.1016/j.neubiorev.2017.09.027] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 10.5] [Reference Citation Analysis]
55 de Bartolomeis A, Buonaguro EF, Latte G, Rossi R, Marmo F, Iasevoli F, Tomasetti C. Immediate-Early Genes Modulation by Antipsychotics: Translational Implications for a Putative Gateway to Drug-Induced Long-Term Brain Changes. Front Behav Neurosci 2017;11:240. [PMID: 29321734 DOI: 10.3389/fnbeh.2017.00240] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
56 Lum JS, Pan B, Deng C, Huang XF, Ooi L, Newell KA. Effects of short- and long-term aripiprazole treatment on Group I mGluRs in the nucleus accumbens: Comparison with haloperidol. Psychiatry Res 2018;260:152-7. [PMID: 29195167 DOI: 10.1016/j.psychres.2017.11.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
57 Costa MDC, Ashraf NS, Fischer S, Yang Y, Schapka E, Joshi G, McQuade TJ, Dharia RM, Dulchavsky M, Ouyang M, Cook D, Sun D, Larsen MJ, Gestwicki JE, Todi SV, Ivanova MI, Paulson HL. Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3. Brain 2016;139:2891-908. [PMID: 27645800 DOI: 10.1093/brain/aww228] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
58 Slim M, Medina-Caliz I, Gonzalez-Jimenez A, Cabello MR, Mayoral-Cleries F, Lucena MI, Andrade RJ. Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions. Drug Saf 2016;39:925-43. [PMID: 27449495 DOI: 10.1007/s40264-016-0436-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
59 Scheggi S, Pelliccia T, Gambarana C, De Montis MG. Aripiprazole relieves motivational anhedonia in rats. J Affect Disord 2018;227:192-7. [PMID: 29100151 DOI: 10.1016/j.jad.2017.10.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
60 Tarland E, Franke RT, Fink H, Pertz HH, Brosda J. Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, on cognitive dysfunction and social aversion in rats. Psychopharmacology (Berl) 2018;235:99-108. [PMID: 28971230 DOI: 10.1007/s00213-017-4747-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
61 Subbaiah MAM. Triple Reuptake Inhibitors as Potential Therapeutics for Depression and Other Disorders: Design Paradigm and Developmental Challenges. J Med Chem 2018;61:2133-65. [DOI: 10.1021/acs.jmedchem.6b01827] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
62 Chouinard G, Samaha AN, Chouinard VA, Peretti CS, Kanahara N, Takase M, Iyo M. Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy. Psychother Psychosom 2017;86:189-219. [PMID: 28647739 DOI: 10.1159/000477313] [Cited by in Crossref: 92] [Cited by in F6Publishing: 103] [Article Influence: 18.4] [Reference Citation Analysis]
63 Muneer A. Wnt and GSK3 Signaling Pathways in Bipolar Disorder: Clinical and Therapeutic Implications. Clin Psychopharmacol Neurosci 2017;15:100-14. [PMID: 28449557 DOI: 10.9758/cpn.2017.15.2.100] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 7.6] [Reference Citation Analysis]
64 Mereu M, Contarini G, Buonaguro EF, Latte G, Managò F, Iasevoli F, de Bartolomeis A, Papaleo F. Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder. Neuropharmacology 2017;121:179-94. [PMID: 28454982 DOI: 10.1016/j.neuropharm.2017.04.037] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 5.8] [Reference Citation Analysis]
65 Casida JE. Why Prodrugs and Propesticides Succeed. Chem Res Toxicol 2017;30:1117-26. [PMID: 28334528 DOI: 10.1021/acs.chemrestox.7b00030] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
66 Frank GK, Shott ME, Hagman JO, Schiel MA, DeGuzman MC, Rossi B. The partial dopamine D2 receptor agonist aripiprazole is associated with weight gain in adolescent anorexia nervosa. Int J Eat Disord 2017;50:447-50. [PMID: 28334444 DOI: 10.1002/eat.22704] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 7.2] [Reference Citation Analysis]
67 Bonifazi A, Yano H, Ellenberger MP, Muller L, Kumar V, Zou MF, Cai NS, Guerrero AM, Woods AS, Shi L, Newman AH. Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism. J Med Chem 2017;60:2890-907. [PMID: 28300398 DOI: 10.1021/acs.jmedchem.6b01875] [Cited by in Crossref: 25] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
68 Rafaniello C, Pozzi M, Pisano S, Ferrajolo C, Bertella S, Sportiello L, Carnovale C, Sullo MG, Cattaneo D, Gentili M, Rizzo R, Pascotto A, Mani E, Villa L, Riccio MP, Sperandeo S, Bernardini R, Bravaccio C, Clementi E, Molteni M, Rossi F, Radice S, Capuano A. Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switch. Expert Opin Drug Saf 2016;15:1-8. [PMID: 27875914 DOI: 10.1080/14740338.2016.1229301] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
69 Kanaan AS, Gerasch S, García-garcía I, Lampe L, Pampel A, Anwander A, Near J, Möller HE, Müller-vahl K. Pathological glutamatergic neurotransmission in Gilles de la Tourette syndrome. Brain 2016;140:218-34. [DOI: 10.1093/brain/aww285] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 5.2] [Reference Citation Analysis]
70 Jóźwiak-Bębenista M, Kowalczyk E. Neuroleptic Drugs and PACAP Differentially Affect the mRNA Expression of Genes Encoding PAC1/VPAC Type Receptors. Neurochem Res 2017;42:943-52. [PMID: 27900577 DOI: 10.1007/s11064-016-2127-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
71 Heitzmann E, Javelot H, Weiner L, Michel B. A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution. Case Rep Psychiatry 2016;2016:7031245. [PMID: 27818825 DOI: 10.1155/2016/7031245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
72 Asada M, Mizutani S, Takagi M, Suzuki H. Antipsychotics promote neural differentiation of human iPS cell-derived neural stem cells. Biochemical and Biophysical Research Communications 2016;480:615-21. [DOI: 10.1016/j.bbrc.2016.10.102] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
73 Schreiner A, Bergmans P, Cherubin P, Hargarter L. The effect of long-acting paliperidone palmitate once-monthly on negative and depressive symptoms in patients with schizophrenia switched from previous unsuccessful treatment with oral aripiprazole. Ther Adv Psychopharmacol 2017;7:59-65. [PMID: 28255435 DOI: 10.1177/2045125316673012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
74 Gerasch S, Kanaan AS, Jakubovski E, Müller-Vahl KR. Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette Syndrome. Front Neurosci 2016;10:416. [PMID: 27672358 DOI: 10.3389/fnins.2016.00416] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
75 Zhou T, Baytunca B, Yu X, Öngür D. Schizo-Obsessive Disorder: the Epidemiology, Diagnosis, and Treatment of Comorbid Schizophrenia and OCD. Curr Treat Options Psych 2016;3:235-45. [DOI: 10.1007/s40501-016-0085-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
76 Orsolini L, Tomasetti C, Valchera A, Vecchiotti R, Matarazzo I, Vellante F, Iasevoli F, Buonaguro EF, Fornaro M, Fiengo AL, Martinotti G, Mazza M, Perna G, Carano A, De Bartolomeis A, Di Giannantonio M, De Berardis D. An update of safety of clinically used atypical antipsychotics. Expert Opin Drug Saf 2016;15:1329-47. [PMID: 27347638 DOI: 10.1080/14740338.2016.1201475] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 11.7] [Reference Citation Analysis]
77 Muneer A. Pharmacotherapy of Acute Bipolar Depression in Adults: An Evidence Based Approach. Korean J Fam Med 2016;37:137-48. [PMID: 27274384 DOI: 10.4082/kjfm.2016.37.3.137] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
78 Pisano S, Catone G, Veltri S, Lanzara V, Pozzi M, Clementi E, Iuliano R, Riccio MP, Radice S, Molteni M, Capuano A, Gritti A, Coppola G, Milone A, Bravaccio C, Masi G. Update on the safety of second generation antipsychotics in youths: a call for collaboration among paediatricians and child psychiatrists. Ital J Pediatr 2016;42:51. [PMID: 27209326 DOI: 10.1186/s13052-016-0259-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
79 Martinotti G, Orsolini L, Fornaro M, Vecchiotti R, De Berardis D, Iasevoli F, Torrens M, Di Giannantonio M. Aripiprazole for relapse prevention and craving in alcohol use disorder: current evidence and future perspectives. Expert Opinion on Investigational Drugs 2016;25:719-28. [DOI: 10.1080/13543784.2016.1175431] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
80 Muneer A. The Treatment of Adult Bipolar Disorder with Aripiprazole: A Systematic Review. Cureus 2016;8:e562. [PMID: 27190727 DOI: 10.7759/cureus.562] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
81 Delorme C, Salvador A, Voon V, Roze E, Vidailhet M, Hartmann A, Worbe Y. Illusion of agency in patients with Gilles de la Tourette Syndrome. Cortex 2016;77:132-40. [DOI: 10.1016/j.cortex.2016.02.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]